OBJECTIVE: To examine the hypothesis that neutrophil chemotaxis to interleukin-8 (IL-8) is reduced in septic shock. Surface expression of neutrophil CXC chemokine receptors and the adhesion molecule CD11b were also examined and associations between disease severity, gas exchange and receptor expression were studied. DESIGN: Prospective cohort clinical study. SETTING. Intensive care unit in a tertiary referral teaching hospital. PATIENTS: Patients with septic shock ( n=15) and healthy controls ( n=8) were studied. MEASUREMENTS AND RESULTS: Daily (for 5 consecutive days) flow cytometric measurements of chemokine and beta integrin surface expression. "In vitro" neutrophil chemotaxis to IL-8 was also compared between patients with sepsis and healthy controls. CXCR2 expression significantly fell, CD11b expression increased and CXCR1 expression was unchanged throughout the study in the septic group compared with healthy controls. CD11b positively correlated with increasing APACHE II scores ( p<0.0001) and worsening PaO(2)/FIO(2) ratios ( p<0.0001). CXCR2 expression negatively correlated with both APACHE II scores ( p=0.016) and PaO(2)/FIO(2) ratios ( p=0.01). There was no correlation between CXCR1 expression and either APACHE II score or PaO(2)/FIO(2) ratios. Chemotaxis to IL-8 was reduced in patients with sepsis compared with healthy volunteers. CONCLUSIONS: Surface expression of the chemokine receptor CXCR2 and the beta-integrin CD11b, but not CXCR1, were reduced on neutrophils isolated from patients with septic shock compared with healthy controls. Chemotaxis to IL-8 was also reduced in neutrophils from septic patients compared with healthy controls. The changes in receptor expression correlated with measures of disease severity.
OBJECTIVE: To examine the hypothesis that neutrophil chemotaxis to interleukin-8 (IL-8) is reduced in septic shock. Surface expression of neutrophil CXC chemokine receptors and the adhesion molecule CD11b were also examined and associations between disease severity, gas exchange and receptor expression were studied. DESIGN: Prospective cohort clinical study. SETTING. Intensive care unit in a tertiary referral teaching hospital. PATIENTS: Patients with septic shock ( n=15) and healthy controls ( n=8) were studied. MEASUREMENTS AND RESULTS: Daily (for 5 consecutive days) flow cytometric measurements of chemokine and beta integrin surface expression. "In vitro" neutrophil chemotaxis to IL-8 was also compared between patients with sepsis and healthy controls. CXCR2 expression significantly fell, CD11b expression increased and CXCR1 expression was unchanged throughout the study in the septic group compared with healthy controls. CD11b positively correlated with increasing APACHE II scores ( p<0.0001) and worsening PaO(2)/FIO(2) ratios ( p<0.0001). CXCR2 expression negatively correlated with both APACHE II scores ( p=0.016) and PaO(2)/FIO(2) ratios ( p=0.01). There was no correlation between CXCR1 expression and either APACHE II score or PaO(2)/FIO(2) ratios. Chemotaxis to IL-8 was reduced in patients with sepsis compared with healthy volunteers. CONCLUSIONS: Surface expression of the chemokine receptor CXCR2 and the beta-integrin CD11b, but not CXCR1, were reduced on neutrophils isolated from patients with septic shock compared with healthy controls. Chemotaxis to IL-8 was also reduced in neutrophils from septic patients compared with healthy controls. The changes in receptor expression correlated with measures of disease severity.
Authors: A D Chishti; J H Dark; P Kesteven; H Powell; C Snowden; B K Shenton; J A Kirby; S V Baudouin Journal: J Thorac Cardiovasc Surg Date: 2001-12 Impact factor: 5.209
Authors: C J Cummings; T R Martin; C W Frevert; J M Quan; V A Wong; S M Mongovin; T R Hagen; K P Steinberg; R B Goodman Journal: J Immunol Date: 1999-02-15 Impact factor: 5.422
Authors: Beatriz M Tavares-Murta; Mateus Zaparoli; Rogério B Ferreira; Mário León Silva-Vergara; Cristina H B Oliveira; Eddie Fernando C Murta; Sérgio H Ferreira; Fernando Q Cunha Journal: Crit Care Med Date: 2002-05 Impact factor: 7.598
Authors: Peter Andrews; Elie Azoulay; Massimo Antonelli; Laurent Brochard; Christian Brun-Buisson; Geoffrey Dobb; Jean-Yves Fagon; Herwig Gerlach; Johan Groeneveld; Jordi Mancebo; Philipp Metnitz; Stefano Nava; Jerome Pugin; Michael Pinsky; Peter Radermacher; Christian Richard; Robert Tasker; Benoit Vallet Journal: Intensive Care Med Date: 2005-02-18 Impact factor: 17.440
Authors: S M Lewis; D F Treacher; J Edgeworth; G Mahalingam; C S Brown; T A Mare; M Stacey; R Beale; K A Brown Journal: Clin Exp Immunol Date: 2015-09-22 Impact factor: 4.330
Authors: Fabricia Petronilho; Francieli Vuolo; Letícia Selinger Galant; Larissa Constantino; Cristiane Damiani Tomasi; Vinicius Renne Giombelli; Cláudio Teodoro de Souza; Sabrina da Silva; Denise Frediani Barbeiro; Francisco Garcia Soriano; Emílio Luiz Streck; Cristiane Ritter; Alfeu Zanotto-Filho; Matheus Augusto Pasquali; Daniel Pens Gelain; José Luiz Rybarczyk-Filho; José Cláudio Fonseca Moreira; Norman L Block; Rafael Roesler; Gilberto Schwartsmann; Andrew V Schally; Felipe Dal-Pizzol Journal: Mol Med Date: 2012-10-24 Impact factor: 6.354
Authors: Jose C Alves-Filho; Andressa Freitas; Fabricio O Souto; Fernando Spiller; Heitor Paula-Neto; Joao S Silva; Ricardo T Gazzinelli; Mauro M Teixeira; Sergio H Ferreira; Fernando Q Cunha Journal: Proc Natl Acad Sci U S A Date: 2009-02-20 Impact factor: 11.205
Authors: Sally A Madsen-Bouterse; Roberto Romero; Adi L Tarca; Juan Pedro Kusanovic; Jimmy Espinoza; Chong Jai Kim; Jung-Sun Kim; Samuel S Edwin; Ricardo Gomez; Sorin Draghici Journal: Am J Reprod Immunol Date: 2010-01 Impact factor: 3.886